<DOC>
	<DOCNO>NCT00752960</DOCNO>
	<brief_summary>The purpose study assess patient treat antipsychotic aripiprazole ( Abilify® ) , olanzapine ( Zyprexa® ) , quetiapine ( Seroquel® ) , risperidone ( Risperdal® ) , ziprasidone ( Geodon® ) identify genetic variation commonly find individual develop diabetic metabolic sign symptom , include change blood lipid , blood glucose , blood pressure , body weight .</brief_summary>
	<brief_title>DNA Diagnostics Minimizing Metabolic Side-Effects Antipsychotics</brief_title>
	<detailed_description>As many 30 % psychiatric patient experience weight gain , central deposition fat , dyslipidemia , increase blood glucose hypertension -- diabetic metabolic symptom -- upon treatment atypical antipsychotic medication . As result , cardiovascular disease risk significantly increase . The long-term goal collaborative study identify , individual atypical antipsychotic ( AAP ) medication , gene variation associate elevated risk diabetic metabolic symptom ( DiMS ) . If gene identify , future genetic testing may help mental health care professional choose treatment minimizing risk undesirable side effect antipsychotic . We propose develop novel product term `` Physiotype '' deliver personalize information patient drug specific risk among aripiprazole , olanzapine , quetiapine , risperidone , ziprasidone . The Physiotype consist multi-gene ensemble single nucleotide polymorphism ( SNPs ) , interpreted biomathematical algorithm , may explain inter-individual difference DiMS among 5 AAPs . If study identify relate gene , genetic test develop provide patient health care professional tool identify patient risk develop adverse metabolic side effect antipsychotic .</detailed_description>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>receive atypical antipsychotic therapy ( olanzapine , aripiprazole , quetiapine , risperidone , ziprasidone ) 3 month take &gt; 50 % prescribe dose last month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>single nucleotide polymorphism , SNP , aripiprazole , olanzapine , quetiapine , risperidone , ziprasidone , metabolic syndrome</keyword>
</DOC>